Stocks and Investing Stocks and Investing
Tue, March 10, 2020
Mon, March 9, 2020

Kevin Huang Upgraded (BSX) to Strong Buy and Decreased Target to $47 on, Mar 9th, 2020


Published on 2024-10-26 23:24:09 -
  Print publication without navigation


Kevin Huang of CFRA, Upgraded "Boston Scientific Corporation" (BSX) to Strong Buy and Decreased Target from $50 to $47 on, Mar 9th, 2020.

Kevin has made no other calls on BSX in the last 4 months.



There are 7 other peers that have a rating on BSX. Out of the 7 peers that are also analyzing BSX, 1 agrees with Kevin's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Amit Hazan of "Goldman Sachs" Initiated at Hold and Held Target at $46 on, Thursday, February 13th, 2020


These are the ratings of the 6 analyists that currently disagree with Kevin


  • Matt Miksic of "Credit Suisse" Maintained at Buy with Decreased Target to $46 on, Friday, March 6th, 2020
  • Joshua Jennings of "Cowen & Co." Maintained at Buy with Increased Target to $52 on, Monday, December 30th, 2019
  • Robbie Marcus of "JP Morgan" Maintained at Buy with Increased Target to $55 on, Friday, December 20th, 2019
  • Mike Matson of "Needham" Downgraded at Strong Buy on, Thursday, December 19th, 2019
  • Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Increased Target to $51 on, Tuesday, December 17th, 2019
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $52 on, Monday, December 16th, 2019